Supernus Pharmaceuticals | SUPN - Equity Capital And Reserves

Stock Price
49.16
Daily Change
0.08 0.16%
Monthly
-0.20%
Yearly
26.54%
Q1 Forecast
46.68

Supernus Pharmaceuticals reported $1.05B in Equity Capital and Reserves for its fiscal quarter ending in September of 2025.





Equity Capital And Reserves Change Date
Abbott USD 50.83B 0 Sep/2025
ANI Pharmaceuticals USD 505.82M 69.06M Sep/2025
Aurora Cannabis CAD 567.1M 21.58M Sep/2025
Bristol-Myers Squibb USD 18.55B 1.06B Sep/2025
Canopy Growth CAD 736.01M 247.04M Sep/2025
Corcept Therapeutics USD 631.9M 3.89M Sep/2025
Eisai JPY 854.43B 25.92B Sep/2025
Eli Lilly USD 23.79B 5.52B Sep/2025
Novo Nordisk DKK 194.05B 24.15B Dec/2025
Pacira USD 727.21M 30.55M Sep/2025
Perrigo USD 4.45B 25.8M Sep/2025
Pfizer USD 92.8B 4.11B Sep/2025
Supernus Pharmaceuticals USD 1.05B 14.23M Sep/2025
United Therapeutics USD 6.59B 583.4M Sep/2025
Xeris Pharmaceuticals USD -861K 18.44M Sep/2025